Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls
- 1 June 1986
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 52 (3) , 803-811
- https://doi.org/10.1128/iai.52.3.803-811.1986
Abstract
Streptococci and streptococcal cell wall fragments induce arthritis in rats, with the severity and duration depending on the capacity of the cells or cell fragments to resist degradation by tissue enzymes. Their phlogogenic effects are apparently related to their ability to activate the alternate complement pathway (ACP). The in vitro activation of the ACP by lysozyme-treated cells and cell walls of group A, B, and D streptococci suggests that both rat and human lysozyme can modulate this activity, i.e., increasing it, decreasing it, or doing both in that order. The effects of the lysozymes also correlated with the degree to which they can unmask the aminosugar-reducing groups detectable in a given amount of cell wall, which suggests that partial depolymerization of the cell wall is critical for ACP activation. The effects of mutanolysin and C phage lysin on ACP activation were found to be correlated with their action on streptococcal cell walls. Neuraminidase had relatively little effect on ACP activation by most streptococcal strains tested. We conclude that the participation of tissue enzymes, including but not necessarily limited to lysozyme, is an important determinant for the clinical arthritis induced by group A, B, or D streptococci. Experimental arthritis induced in rats with whole (or disrupted) streptococci may depend both on the capacities of the cell walls to activate the ACP and on the capacities of the host tissue enzymes to modulate this activation. Great severity and long durations of the disease were determined by the capacity of the enzymes to degrade cell wall antigens to a degree sufficient to ensure efficient activation of the ACP without completely degrading the material so that it no longer activates complement. In this model, the limited resistance of group B peptidoglycan to lysozyme was a critical pathogenic factor.This publication has 34 references indexed in Scilit:
- Treatment of experimental erosive arthritis in rats by injection of the muralytic enzyme mutanolysin.The Journal of Experimental Medicine, 1984
- The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.The Journal of Experimental Medicine, 1980
- Arthritis in rats after systemic injection of streptococcal cells or cell walls.The Journal of Experimental Medicine, 1977
- On the inhibition of hen egg-white lysozyme activity by aminoglycosidic antibioticsBiochemical and Biophysical Research Communications, 1977
- Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway.The Journal of Experimental Medicine, 1976
- PURIFICATION AND PHYSICAL PROPERTIES OF GROUP C STREPTOCOCCAL PHAGE-ASSOCIATED LYSINThe Journal of Experimental Medicine, 1971
- CHEMOTAXIS OF MONONUCLEAR CELLSThe Journal of Experimental Medicine, 1968
- A modification of the Park and Johnson reducing sugar determination suitable for the assay of insoluble materials: Its application to bacterial cell wallsAnalytical Biochemistry, 1968
- PERSISTENCE OF GROUP A STREPTOCOCCAL CELL WALLS RELATED TO CHRONIC INFLAMMATION OF RABBIT DERMAL CONNECTIVE TISSUEThe Journal of Experimental Medicine, 1967
- Properdin System and Immunity: II. Interaction of the Properdin System with PolysaccharidesScience, 1955